Skip to Content

Brain

Please click on the protocol number for additional information.

NCCTG N0872:  Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme

NCCTG N0877: Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

RTOG 1122:  Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumor